Invidious
Global Resource for Advancing Cancer Education
Subscribe | 6.5K
 RSS

The Global Resource for Advancing Cancer Education (GRACE:www.cancergrace.org) is a nonprofit organization founded by doctors, nurses, and other specialists who are committed to improving the care that cancer patients receive. The content here is provided by cancer experts for patients and caregivers on a range of oncology topics.

View channel on YouTube
Switch Invidious Instance
Videos
Shorts
Livestreams
Playlists
Posts
newest
oldest
popular
Next page  

3:08

Why Biomarker Education is Crucial in Getting the Right Treatment - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

11 views

3:34

Biomarker Testing for Surgically Resected NSCLC or Considering - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

15 views

2:13

PD-L1: A Key Biomarker that Can Help Decide Treatment - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

17 views

3:46

Why Biomarker Testing is Important in Non-Small Cell Lung Cancer - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

7 views

5:36

Methods for Biomarker Testing in Non-Small Cell Lung Cancer - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

6 views

3:17

Who Should Get Biomarker Testing in Non-Small Cell Lung Cancer? - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

7 views

3:16

Ongoing Clinical Trials for HER-2 Mutated Lung Cancer - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

10 views

5:21

Treating HER-2 Mutated Lung Cancer: Zongertinib - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

6 views

6:52

Treating HER-2 Mutated Lung Cancer: Trastuzumab Deruxtecan - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

10 views

3:42

How to Test for HER-2 Mutations - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

3 views

4:54

What Are HER-2 Mutations? - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

6 views

5:18

Sunvozertinib for NSCLC with EGFR Exon 20 - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

19 views

9:47

Targeting TROP2: Datopotamab Deruxtecan (Dato-DXd) - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

20 views

8:02

Telisotuzumab Vedotin for MET-Positive Non-Small Cell Lung Cancer - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

12 views

9:02

Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer - Lung Cancer OncInsights 2025-26

Global Resource for Advancing Cancer Education

Shared 1 week ago

10 views

2:28:07

Lung Cancer OncTalk December 2025 OnDemand

Global Resource for Advancing Cancer Education

Shared 1 week ago

87 views

4:05

When is it a Good Time to Have Your Case Discussed in a Tumor Board? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

16 views

3:11

Does Multiple Myeloma Spread in the Body and Who is at Risk for it? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

12 views

3:03

What's the Best Treatment for Myeloma and Severe Neuropathy? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

15 views

3:51

How Do You Know What Subtype of Acute Myeloid Leukemia You Have? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

6 views

2:44

Autologous vs. Allogeneic Stem Cell Transplant - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

8 views

5:14

How Long Does a Stem Cell Transplant Take and How Long is Recovery? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

5 views

8:44

MRD and Mass Spectrometry in Multiple Myeloma and Lymphoma - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

12 views

3:54

Multiple Myeloma: What VRd is and How to Approach Post VRd - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

10 views

4:14

Neurotoxicity of CAR T-Cell Therapy and How Often it Occurs - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

11 views

4:09

Which Phase of Treatment Will Cell Therapy Be In the Future? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

2 views

4:16

Cost and Accessibility of Cell and Gene Therapies and T-Cell Lymphoma - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

4 views

2:00

What's Next in Cell Therapies? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

3 views

8:50

Current Cell and Gene Therapies and Side Effects - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

12 views

3:31

Cell Therapy Timeline - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

1 view

5:25

Cell Therapies and Cell Collection - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

5 views

4:51

Autologous and Allogeneic Hematopoietic Stem Cell Transplantation - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

7 views

4:01

Questions to Ask Your Doctor about T-Cell Lymphoma - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

2 views

5:00

Managing Side Effects of T-Cell Lymphoma and Staying Well - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

2 views

4:39

How to Treat T-Cell Lymphoma - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

3 views

3:43

How to Diagnose Peripheral T-Cell Lymphoma - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

1 view

7:37

T-Cells, T-Cell Lymphoma and Importance of Correct Diagnosis - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

3 views

3:40

Redefining the Word "Cure" in Multiple Myeloma - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

10 views

3:18

Multiple Myeloma Lines of Therapy and Successes - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

4 views

4:49

What Causes Multiple Myeloma? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

4 views

5:49

CAR T-Cell Therapy and Bispecific Antibody Therapy for Returning MM - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

5 views

3:03

Current Standard of Treatment in Newly Diagnosed Multiple Myeloma - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

27 views

4:51

Multiple Myeloma Testing to Diagnose, Track and Decide When to Treat - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

9 views

3:46

Natural Course of Multiple Myeloma - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

8 views

4:52

Overview of Multiple Myeloma - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

6 views

4:46

VEXAS Syndrome and MDS/MPN Overlap Syndrome - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

15 views

5:56

Treatment Options for Myelodysplastic Syndromes/Neoplasms - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

11 views

3:20

Myelodysplastic Syndromes/Neoplasms Prognostication - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

5 views

5:30

What are Myelodysplastic Syndromes/Neoplasms? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

3 views

7:43

What is Clonal Hematopoiesis? - Blood Cancers OncTalk 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

9 views

5:18

Future Advances - Head and Neck Cancer OncPanel 2025-2026

Global Resource for Advancing Cancer Education

Shared 1 month ago

48 views

4:24

Perioperative Chemoimmunotherapy - Head and Neck Cancer OncPanel 2025-2026

Global Resource for Advancing Cancer Education

Shared 1 month ago

16 views

5:03

Emerging Study Data in 2025 - Head and Neck Cancer OncPanel 2025-2026

Global Resource for Advancing Cancer Education

Shared 1 month ago

13 views

2:42

Future Directions for Perioperative Immunotherapy - Head and Neck Cancer OncPanel 2025-2026

Global Resource for Advancing Cancer Education

Shared 1 month ago

4 views

1:46

Subcutaneous Immunotherapy - Head and Neck Cancer OncPanel 2025-2026

Global Resource for Advancing Cancer Education

Shared 1 month ago

12 views

4:19

The Gortec Trial: Nivolumab for High Risk Patients - Head and Neck Cancer OncPanel 2025-2026

Global Resource for Advancing Cancer Education

Shared 1 month ago

13 views

4:30

Perioperative Pembrolizumab: New FDA Approval - Head and Neck Cancer OncPanel 2025-2026

Global Resource for Advancing Cancer Education

Shared 1 month ago

8 views

4:34

Keynote 689: Studying the Standard of Care - Head and Neck Cancer OncPanel 2025-2026

Global Resource for Advancing Cancer Education

Shared 1 month ago

9 views

5:07

Key Definitions in Head and Neck Cancer Treatment - Head and Neck Cancer OncPanel 2025-2026

Global Resource for Advancing Cancer Education

Shared 1 month ago

15 views

1:03:37

The Wild West of Melanoma, Side Effects - Ginny Haessly Clinical Trials Storytelling 2025

Global Resource for Advancing Cancer Education

Shared 1 month ago

9 views

Next page